Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d'Etudes et de Recherche sur …
…, P Delaval, J Cadranel, P Bonniaud, G Prévot… - Autoimmunity …, 2017 - Elsevier
… Patients with asthma and blood eosinophils > 1.5 G/L and systemic manifestations shall
be called Hyper Eosinophilic Asthma with (any) Systemic (non vasculitic) Manifestations (HASM) …
be called Hyper Eosinophilic Asthma with (any) Systemic (non vasculitic) Manifestations (HASM) …
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
…, B Philippe, G Prévot… - European …, 2014 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is the most frequent chronic idiopathic interstitial pneumonia
in adults. The management of rare diseases in France has been organised by a national …
in adults. The management of rare diseases in France has been organised by a national …
Démonstration de l'existence d'un cycle marin chez les Strigeides: Cardiocepbalus longicollis Szidat, 1928 (Trematoda: Strigeidae)
G Prévot, P Bartoli - Annales de Parasitologie Humaine et …, 1980 - parasite-journal.org
Au cours de leurs investigations sur le parasitisme des Poissons et des Oiseaux de la
lagune du Brusc (Var), les auteurs ont découvert le cycle de Cardiocephalus longicollis. Les …
lagune du Brusc (Var), les auteurs ont découvert le cycle de Cardiocephalus longicollis. Les …
[HTML][HTML] Management of pulmonary toxicity associated with immune checkpoint inhibitors
M Delaunay, G Prévot, S Collot… - European …, 2019 - Eur Respiratory Soc
… SITC, ASCO and ESMO also suggest considering infliximab (5 mg·kg −1 ), mycophenolate
mofetil intravenously (1 g twice a day) or cyclophosphamide if there is no clinical …
mofetil intravenously (1 g twice a day) or cyclophosphamide if there is no clinical …
[PDF][PDF] French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis. From the National Reference and the Competence centers for …
…, S Kouzan, F Lebargy, SM Adam, B Philippe, G Prévot… - Rev Mal Respir, 2013 - core.ac.uk
La fibrose pulmonaire idiopathique (FPI) est la forme la plus fréquente de pneumopathie
interstitielle diffuse (PID) idiopathique chronique chez l’adulte. Il s’ agit d’une maladie …
interstitielle diffuse (PID) idiopathique chronique chez l’adulte. Il s’ agit d’une maladie …
Recommandations pratiques pour le diagnostic et la prise en charge de la fibrose pulmonaire idiopathique. Élaborées par le centre national de référence et les …
…, S Marchand-Adam, B Philippe, G Prévot… - Revue des maladies …, 2013 - hal.science
… G. Ferreti … G. Prévôt …
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
V Cottin, J Le Pavec, G Prévot, H Mal… - European respiratory …, 2010 - Eur Respiratory Soc
This study aims to describe the haemodynamic and survival characteristics of patients with
pulmonary hypertension in the recently individualised syndrome of combined pulmonary …
pulmonary hypertension in the recently individualised syndrome of combined pulmonary …
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double …
…, N Zhang, Y Mi, X Zhu, P Jansa, G Prévot… - The Lancet …, 2024 - thelancet.com
Background Macitentan is beneficial for long-term treatment of pulmonary arterial
hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) …
hypertension. The microvasculopathy of chronic thromboembolic pulmonary hypertension (CTEPH) …
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open …
…, P Magro, L Savale, G Prévot… - The Lancet …, 2022 - thelancet.com
Background Riociguat and balloon pulmonary angioplasty (BPA) are treatment options for
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients
…, MT Leccia, M Jaffro, S Collot, G Prévot… - European …, 2017 - Eur Respiratory Soc
… centrally by a panel of two radiologists experienced in interstitial lung diseases (Samia Collot
and Marion Jaffro), a pulmonologist specialising in interstitial pneumonitis (Grégorie Prévot…
and Marion Jaffro), a pulmonologist specialising in interstitial pneumonitis (Grégorie Prévot…